why choose us

First received: August 07, 2025

Clinical Trial: A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Thyroid Eye Disease

Study Type: INTERVENTIONAL


Official Title: A Randomized, Open-label Study Evaluating the Safety, Tolerability and Pharmacokinetics of VRDN-003 Administered Subcutaneously in Participants With Thyroid Eye Disease (TED)

Brief Summary: This is a clinical trial assessing the safety, tolerability and pharmacokinetics (PK) of an investigational drug, VRDN-003, in participants with TED (Thyroid Eye Disease)

Read more